Kline, William O.

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology

Muscle Physiology and DisordersMuscle metabolism and nutrition

Cited by 2,752

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell

Muscle Physiology and DisordersFOXO transcription factor regulation

Cited by 1,964

Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy

Lai, K.-M. V., Gonzalez, M., Poueymirou, W. T., Kline, W. O., Na, E., Zlotchenko, E., Stitt, T. N., Economides, A. N., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular and Cellular Biology

Muscle Physiology and DisordersMuscle metabolism and nutrition

Cited by 442

Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol

Kline, W. O., Panaro, F. J., Yang, H., & Bodine, S. C. (2007) · Journal of Applied Physiology

Muscle Physiology and DisordersPharmacological Effects and Assays

Cited by 177